Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
J Transl Med ; 19(1): 128, 2021 03 29.
Artículo en Inglés | MEDLINE | ID: mdl-33781275

RESUMEN

BACKGROUND: Omega-3 polyunsaturated fatty acids (n3-PUFAs) may exert beneficial effects on the immune system of patients with viral infections. This paper aimed to examine the effect of n3-PUFA supplementation on inflammatory and biochemical markers in critically ill patients with COVID-19. METHODS: A double-blind, randomized clinical trial study was conducted on 128 critically ill patients infected with COVID-19 who were randomly assigned to the intervention (fortified formula with n3-PUFA) (n = 42) and control (n = 86) groups. Data on 1 month survival rate, blood glucose, sodium (Na), potassium (K), blood urea nitrogen (BUN), creatinine (Cr), albumin, hematocrit (HCT), calcium (Ca), phosphorus (P), mean arterial pressure (MAP), O2 saturation (O2sat), arterial pH, partial pressure of oxygen (PO2), partial pressure of carbon dioxide (PCO2), bicarbonate (HCO3), base excess (Be), white blood cells (WBCs), Glasgow Coma Scale (GCS), hemoglobin (Hb), platelet (Plt), and the partial thromboplastin time (PTT) were collected at baseline and after 14 days of the intervention. RESULTS: The intervention group had significantly higher 1-month survival rate and higher levels of arterial pH, HCO3, and Be and lower levels of BUN, Cr, and K compared with the control group after intervention (all P < 0.05). There were no significant differences between blood glucose, Na, HCT, Ca, P, MAP, O2sat, PO2, PCO2, WBCs, GCS, Hb, Plt, PTT, and albumin between two groups. CONCLUSION: Omega-3 supplementation improved the levels of several parameters of respiratory and renal function in critically ill patients with COVID-19. Further clinical studies are warranted. Trial registry Name of the registry: This study was registered in the Iranian Registry of Clinical Trials (IRCT); Trial registration number: IRCT20151226025699N3; Date of registration: 2020.5.20; URL of trial registry record: https://en.irct.ir/trial/48213.


Asunto(s)
COVID-19/dietoterapia , COVID-19/diagnóstico , Enfermedad Crítica/terapia , Ácidos Grasos Omega-3/farmacología , Adulto , Anciano , Anciano de 80 o más Años , Biomarcadores/análisis , Biomarcadores/sangre , Análisis de los Gases de la Sangre , Glucemia/efectos de los fármacos , Glucemia/metabolismo , COVID-19/mortalidad , COVID-19/fisiopatología , Enfermedad Crítica/mortalidad , Suplementos Dietéticos , Método Doble Ciego , Ácidos Grasos Omega-3/administración & dosificación , Femenino , Hematócrito , Humanos , Mediadores de Inflamación/análisis , Mediadores de Inflamación/sangre , Irán/epidemiología , Riñón/efectos de los fármacos , Riñón/fisiopatología , Riñón/virología , Masculino , Persona de Mediana Edad , Mortalidad , Pronóstico , Sistema Respiratorio/efectos de los fármacos , Sistema Respiratorio/fisiopatología , Sistema Respiratorio/virología , SARS-CoV-2/efectos de los fármacos , Análisis de Supervivencia , Resultado del Tratamiento
2.
Medicine (Baltimore) ; 99(30): e21320, 2020 Jul 24.
Artículo en Inglés | MEDLINE | ID: mdl-32791725

RESUMEN

BACKGROUND: Assessing the effectiveness and safety of traditional Chinese medicine (TCM) for symptoms of upper respiratory tract of coronavirus disease 2019 is the main purpose of this systematic review protocol. METHODS: The following electronic databases will be searched from inception to Sep 2020: the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, EMBASE, Web of Science, TCM, China National Knowledge Infrastructure, Chinese Biomedical Literature Database, Chinese Scientific Journal Database (VIP database), and Wan-Fang Database. Search dates: from inception dates to June 2020. Language: English. Publication period: from inception dates to June 2020. The primary outcome is the time and rate of appearance of main symptoms (including coughing, pharyngalgia, and nasal obstruction). The secondary outcome is the length of hospital stay. Two independent reviewers will conduct the study selection, data extraction and assessment. RevMan V.5.3 will be used for the assessment of risk of bias and data synthesis. RESULTS: The results will provide a high-quality synthesis of current evidence for researchers in this subject area. CONCLUSION: The conclusion of our study will provide an evidence to judge whether TCM is effective and safe for the patients with symptoms of upper respiratory tract of coronavirus disease 2019. ETHICS AND DISSEMINATION: This protocol will not evaluate individual patient information or affect patient rights and therefore does not require ethical approval. Results from this review will be disseminated through peer-reviewed journals and conference reports. PROSPERO REGISTRATION NUMBER: CRD42020187422.


Asunto(s)
Betacoronavirus , Infecciones por Coronavirus/terapia , Medicina Tradicional China/métodos , Neumonía Viral/terapia , Infecciones del Sistema Respiratorio/terapia , COVID-19 , Infecciones por Coronavirus/patología , Infecciones por Coronavirus/virología , Humanos , Metaanálisis como Asunto , Pandemias , Neumonía Viral/patología , Neumonía Viral/virología , Ensayos Clínicos Controlados Aleatorios como Asunto , Proyectos de Investigación , Sistema Respiratorio/virología , Infecciones del Sistema Respiratorio/patología , Infecciones del Sistema Respiratorio/virología , SARS-CoV-2 , Revisiones Sistemáticas como Asunto , Resultado del Tratamiento
3.
Virus Res ; 273: 197767, 2019 11.
Artículo en Inglés | MEDLINE | ID: mdl-31560964

RESUMEN

Human coronavirus NL63 (HCoV-NL63), one of the main circulating HCoVs worldwide, causes respiratory tract illnesses like runny nose, cough, bronchiolitis and pneumonia. Recently, a severe respiratory illness outbreak of HCoV-NL63 has been reported in a long-term care facility. Sambucus FormosanaNakai, a species of elderberry, is a traditional medicinal herb with anti-inflammatory and antiviral potential. The study investigated the antiviral activity of Sambucus FormosanaNakai stem ethanol extract and some phenolic acid constituents against HCoV-NL63. The extract was less cytotoxic and concentration-dependently increased anti-HCoV-NL63 activities, including cytopathicity, sub-G1 fraction, virus yield (IC50 = 1.17 µg/ml), plaque formation (IC50 = 4.67 µg/ml) and virus attachment (IC50 = 15.75 µg/ml). Among the phenolic acid constituents in Sambucus FormosanaNakai extract, caffeic acid, chlorogenic acid and gallic acid sustained the anti-HCoV-NL63 activity that was ranked in the following order of virus yield reduction: caffeic acid (IC50 = 3.54 µM) > chlorogenic acid (IC50 = 43.45 µM) > coumaric acid (IC50 = 71.48 µM). Caffeic acid significantly inhibited the replication of HCoV-NL63 in a cell-type independent manner, and specifically blocked virus attachment (IC50 = 8.1 µM). Therefore, the results revealed that Sambucus Formosana Nakai stem ethanol extract displayed the strong anti-HCoV-NL63 potential; caffeic acid could be the vital component with anti-HCoV-NL63 activity. The finding could be helpful for developing antivirals against HCoV-NL63.


Asunto(s)
Antivirales/farmacología , Coronavirus Humano NL63/efectos de los fármacos , Células Epiteliales/efectos de los fármacos , Hidroxibenzoatos/farmacología , Extractos Vegetales/farmacología , Sambucus/química , Animales , Línea Celular , Supervivencia Celular/efectos de los fármacos , Infecciones por Coronavirus , Células Epiteliales/virología , Humanos , Hidroxibenzoatos/química , Concentración 50 Inhibidora , Riñón/citología , Riñón/virología , Macaca mulatta , Extractos Vegetales/química , Tallos de la Planta/química , Sistema Respiratorio/citología , Sistema Respiratorio/virología , Acoplamiento Viral/efectos de los fármacos
4.
Br Poult Sci ; 59(4): 389-395, 2018 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-29768944

RESUMEN

1. The effect of Zataria multiflora essential oil on replication rate of the H9N2 virus in target organs was determined by real-time PCR. One-day-old broiler chicks were randomly divided into six groups and were challenged with H9N2 influenza. Two groups received either 20 or 40 µl/kg body weight/day Zataria multiflora essential oils (ZM) seven days before the challenge while two other groups received the essential oil at the same dosage but after H9N2 challenge. One group received 4 mg/kg body weight/day of the anti-viral compound amantadine after challenge and the last group received no treatment and served as the control. 2. Groups that received the ZM, before or after H9N2 challenge, and the amantadine treated group showed reduced viral replication in the respiratory and gastrointestinal tracts compared to the control. Supplementation with ZM improved weight gain and FCR in broilers in comparison with the control. 3. The results showed that ZM had a positive effect on reducing viral replication in both the intestine and trachea of H9N2 influenza infected broiler chickens, that led to milder clinical symptoms and better performance.


Asunto(s)
Pollos , Subtipo H9N2 del Virus de la Influenza A/efectos de los fármacos , Lamiaceae/química , Aceites Volátiles/metabolismo , Replicación Viral/efectos de los fármacos , Amantadina/farmacología , Alimentación Animal/análisis , Animales , Antivirales/farmacología , Dieta/veterinaria , Suplementos Dietéticos/análisis , Relación Dosis-Respuesta a Droga , Tracto Gastrointestinal/virología , Subtipo H9N2 del Virus de la Influenza A/fisiología , Gripe Aviar/tratamiento farmacológico , Gripe Aviar/fisiopatología , Gripe Aviar/virología , Aceites Volátiles/administración & dosificación , Enfermedades de las Aves de Corral/tratamiento farmacológico , Enfermedades de las Aves de Corral/fisiopatología , Enfermedades de las Aves de Corral/virología , Distribución Aleatoria , Sistema Respiratorio/virología , Replicación Viral/fisiología
5.
Viral Immunol ; 30(10): 737-743, 2017 12.
Artículo en Inglés | MEDLINE | ID: mdl-29130830

RESUMEN

Previous research has evaluated antibody responses toward an influenza virus vaccine in the context of deficiencies for vitamins A and D (VAD+VDD). Results showed that antibodies and antibody-forming cells in the respiratory tract were reduced in VAD+VDD mice. However, effectors were recovered when oral supplements of vitamins A + D were delivered at the time of vaccination. Here we address the question of how vaccine-induced CD8+ T cell responses are affected by deficiencies for vitamins A + D. VAD+VDD and control mice were vaccinated with an intranasal, cold-adapted influenza virus A/Puerto Rico/8/34 vaccine, with or without oral supplements of vitamins A + D. Results showed that the percentages of vaccine-induced CD8+ T cell and total CD4+ T cell responses were low among lymphocytes in the airways of VAD+VDD animals compared to controls. The CD103 membrane marker, a protein that binds e-cadherin (expressed on respiratory tract epithelial cells), was unusually high on virus-specific T cells in VAD+VDD mice compared to controls. Interestingly, when T cells specific for the PA224-233/Db epitope were compared with T cells specific for the NP366-374/Db epitope, the former population was more strongly positive for CD103. Preliminary experiments revealed normal or above-normal percentages for vaccine-induced T cells in airways when VAD+VDD animals were supplemented with vitamins A + D at the time of vaccination and on days 3 and 7 after vaccination. Our results suggest that close attention should be paid to levels of vitamins A and D among vaccine recipients in the clinical arena, as low vitamin levels may render individuals poorly responsive to vaccines.


Asunto(s)
Antígenos CD/genética , Linfocitos T CD8-positivos/inmunología , Subtipo H1N1 del Virus de la Influenza A/inmunología , Vacunas contra la Influenza/inmunología , Gripe Humana/inmunología , Cadenas alfa de Integrinas/genética , Deficiencia de Vitamina A/genética , Deficiencia de Vitamina D/genética , Animales , Linfocitos T CD8-positivos/virología , Suplementos Dietéticos , Modelos Animales de Enfermedad , Femenino , Humanos , Vacunas contra la Influenza/administración & dosificación , Gripe Humana/dietoterapia , Gripe Humana/prevención & control , Linfocitos/citología , Linfocitos/inmunología , Linfocitos/virología , Ratones , Ratones Endogámicos C57BL , Sistema Respiratorio/inmunología , Sistema Respiratorio/virología , Resultado del Tratamiento , Regulación hacia Arriba/genética , Vacunación , Deficiencia de Vitamina A/dietoterapia , Deficiencia de Vitamina D/dietoterapia , Vitaminas/administración & dosificación
6.
Planta Med ; 83(7): 615-623, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-27806409

RESUMEN

Chlorogenic acids are secondary metabolites in diverse plants. Some chlorogenic acids extracted from traditional medicinal plants are known for their healing properties, e.g., against viral infections. Also, green coffee beans are a rich source of chlorogenic acids, with 5-O-caffeoylquinic acid being the most abundant chlorogenic acid in coffee. We previously reported the synthesis of the regioisomers of lactones, bearing different substituents on the quinidic core. Here, 3,4-O-dicaffeoyl-1,5-γ-quinide and three dimethoxycinnamoyl-γ-quinides were investigated for in vitro antiviral activities against a panel of 14 human viruses. Whereas the dimethoxycinnamoyl-γ-quinides did not show any antiviral potency in cytopathogenic effect reduction assays, 3,4-O-dicaffeoyl-1,5-γ-quinide exerted mild antiviral activity against herpes simplex viruses, adenovirus, and influenza virus. Interestingly, when the compounds were evaluated against respiratory syncytial virus, a potent antiviral effect of 3,4-O-dicaffeoyl-1,5-γ-quinide was observed against both subtypes of respiratory syncytial virus, with EC50 values in the submicromolar range. Time-of-addition experiments revealed that this compound acts on an intracellular post-entry replication step. Our data show that 3,4-O-dicaffeoyl-1,5-γ-quinide is a relevant candidate for lead optimization and further mechanistic studies, and warrants clinical development as a potential anti-respiratory syncytial virus drug.


Asunto(s)
Antivirales/farmacología , Ácido Clorogénico/uso terapéutico , Café/química , Extractos Vegetales/uso terapéutico , Ácido Quínico/análogos & derivados , Virus/efectos de los fármacos , Animales , Chlorocebus aethiops , Células HEK293 , Células HeLa , Humanos , Orthomyxoviridae/efectos de los fármacos , Ácido Quínico/uso terapéutico , Virus Sincitiales Respiratorios/efectos de los fármacos , Sistema Respiratorio/virología , Células Vero
7.
mBio ; 7(4)2016 08 02.
Artículo en Inglés | MEDLINE | ID: mdl-27486196

RESUMEN

UNLABELLED: Obesity is a risk factor for developing severe influenza virus infection, making vaccination of utmost importance for this high-risk population. However, vaccinated obese animals and adults have decreased neutralizing antibody responses. In these studies, we tested the hypothesis that the addition of either alum or a squalene-based adjuvant (AS03) to an influenza vaccine would improve neutralizing antibody responses and protect obese mice from challenge. Our studies demonstrate that adjuvanted vaccine does increase both neutralizing and nonneutralizing antibody levels compared to vaccine alone. Although obese mice mount significantly decreased virus-specific antibody responses, both the breadth and the magnitude of the responses against hemagglutinin (HA) and neuraminidase (NA) are decreased compared to the responses in lean mice. Importantly, even with a greater than fourfold increase in neutralizing antibody levels, obese mice are not protected against influenza virus challenge and viral loads remain elevated in the respiratory tract. Increasing the antigen dose affords no added protection, and a decreasing viral dose did not fully mitigate the increased mortality seen in obese mice. Overall, these studies highlight that, while the use of an adjuvant does improve seroconversion, vaccination does not fully protect obese mice from influenza virus challenge, possibly due to the increased sensitivity of obese animals to infection. Given the continued increase in the global obesity epidemic, our findings have important implications for public health. IMPORTANCE: Vaccination is the most effective strategy for preventing influenza virus infection and is a key component for pandemic preparedness. However, vaccines may fail to provide optimal protection in high-risk groups, including overweight and obese individuals. Given the worldwide obesity epidemic, it is imperative that we understand and improve vaccine efficacy. No work to date has investigated whether adjuvants increase the protective capacity of influenza vaccines in the obese host. In these studies, we show that adjuvants increased the neutralizing and nonneutralizing antibody responses during vaccination of lean and obese mice to levels considered "protective," and yet, obese mice still succumbed to infection. This vulnerability is likely due to a combination of factors, including the increased susceptibility of obese animals to develop severe and even lethal disease when infected with very low viral titers. Our studies highlight the critical public health need to translate these findings and better understand vaccination in this increasing population.


Asunto(s)
Adyuvantes Inmunológicos/administración & dosificación , Anticuerpos Neutralizantes/sangre , Anticuerpos Antivirales/sangre , Vacunas contra la Influenza/administración & dosificación , Vacunas contra la Influenza/inmunología , Gripe Humana/prevención & control , Obesidad/inmunología , Compuestos de Alumbre/administración & dosificación , Animales , Modelos Animales de Enfermedad , Combinación de Medicamentos , Glicoproteínas Hemaglutininas del Virus de la Influenza/inmunología , Humanos , Subtipo H7N9 del Virus de la Influenza A/aislamiento & purificación , Ratones Endogámicos C57BL , Ratones Obesos , Neuraminidasa/inmunología , Polisorbatos/administración & dosificación , Sistema Respiratorio/virología , Escualeno/administración & dosificación , Análisis de Supervivencia , Resultado del Tratamiento , Carga Viral , Proteínas Virales/inmunología , alfa-Tocoferol/administración & dosificación
8.
Am J Chin Med ; 41(3): 585-99, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23711143

RESUMEN

Paeonia lactiflora Pallas (P. lactiflora, Ranunculaceae) is a common ingredient of Sheng-Ma-Ge-Gen-Tang (SMGGT; Shoma-kakkon-to) and Ge-Gen-Tang (GGT; kakkon-to). SMGGT and GGT are different prescriptions of traditional Chinese medicine with different ingredients designed for airway symptoms. Both SMGGT and GGT have anti-viral activity against human respiratory syncytial virus (HRSV). Therefore, P. lactiflora was hypothesized to be the effective ingredient of both SMGGT and GGT against HRSV. However, P. lactiflora does not have any proven antiviral activity. This study used both human upper (Human larynx epidermoid carcinoma cell line, HEp-2) and lower (human lung carcinoma cell line, A549) respiratory tract cells to test the hypothesis that a hot water extract of P. lactiflora could effectively inhibit plaque formation induced by HRSV infection. The ability of P. lactiflora to stimulate anti-viral cytokines was evaluated by enzyme-linked immunosorbent assay (ELISA). The results showed that P. lactiflora was time-dependently and dose-dependently effective against HRSV in HEp-2 and A549 cells, particularly supplemented before viral inoculation (p < 0.0001). 10 µg/ml P. lactiflora had a comparable anti-HRSV activity with 10 µg/ml ribavirin, a broad-spectrum antiviral agent. P. lactiflora was dose-dependently effective against viral attachment (p < 0.0001), with a better effect on A549 cells (p < 0.0001). P. lactiflora was time-dependently (p < 0.0001) and dose-dependently (p < 0.0001) effective against viral penetration. Moreover, P. lactiflora stimulated IFN-ß secretion without any effect on TNF-α secretion. Therefore, P. lactiflora could be beneficial at preventing HRSV infection by inhibiting viral attachment, internalization, and stimulating IFN secretion.


Asunto(s)
Antivirales/uso terapéutico , Medicamentos Herbarios Chinos/uso terapéutico , Paeonia , Fitoterapia , Infecciones por Virus Sincitial Respiratorio/tratamiento farmacológico , Virus Sincitial Respiratorio Humano/efectos de los fármacos , Sistema Respiratorio/efectos de los fármacos , Antivirales/farmacología , Línea Celular Tumoral , Citocinas/metabolismo , Relación Dosis-Respuesta a Droga , Medicamentos Herbarios Chinos/farmacología , Ensayo de Inmunoadsorción Enzimática , Humanos , Interferón beta/metabolismo , Infecciones por Virus Sincitial Respiratorio/metabolismo , Infecciones por Virus Sincitial Respiratorio/virología , Virus Sincitial Respiratorio Humano/patogenicidad , Sistema Respiratorio/virología , Ribavirina/farmacología , Factor de Necrosis Tumoral alfa/metabolismo , Acoplamiento Viral/efectos de los fármacos , Internalización del Virus/efectos de los fármacos
9.
J Ethnopharmacol ; 148(2): 466-73, 2013 Jul 09.
Artículo en Inglés | MEDLINE | ID: mdl-23643542

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Licorice (Glycyrrhiza uralensis Fisch., Leguminosae) has been used in herbal medicine and food supplement worldwide for centuries. Licorice is a common ingredient of several prescriptions of traditional Chinese medicine which have been proved to inhibit infection of human respiratory syncytial virus (HRSV). There are two preparations of licorice, Radix Glycyrrhizae and Radix Glycyrrhizae Preparata. However, it is unknown whether licorice or which preparation of licorice is effective against HRSV, nor is its active constituent. AIM OF THE STUDY: We tested the hypothesis that Radix Glycyrrhizae can effectively decrease HRSV-induced plaque formation in respiratory mucosal cell lines. We also tried to find out the active constituent. MATERIALS AND METHODS: Anti-HRSV activities of hot water extracts of preparations of licorice, glycyrrhizin and 18ß-glycyrrhetinic acid (18ß-GA), the active constituents of licorice, were examined by plaque reduction assay in both human upper (HEp-2) and low (A549) respiratory tract cell lines. Abilities of crude licorice to inhibit viral replication and to stimulate IFN-ß were evaluated by reverse transcription polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA), respectively. RESULTS: Radix Glycyrrhizae and Radix Glycyrrhizae Preparata dose-dependently inhibited HRSV-induced plaque formation in both HEp-2 and A549 cell lines (p<0.0001). The effect of Radix Glycyrrhizae was better than that of Radix Glycyrrhizae Preparata on HEp-2 cells. However, there was no difference of their anti-HRSV effects on A549 cells. Besides, glycyrrhizin was ineffective at all. Nevertheless, 18ß-GA showed a potent anti-HRSV activity. Radix Glycyrrhizae was more effective when given before viral inoculation (p<0.0001) which may be due to its inhibition of viral attachment on (p<0.0001) and penetration (p<0.0001) into the host cells. The anti-HRSV activity of Radix Glycyrrhizae was further confirmed by RT-PCR and qRT-PCR. 300 µg/ml Radix Glycyrrhizae markedly decreased the viral amounts within the cells and in the suspension. Radix Glycyrrhizae might further stimulate mucosal cells to secrete IFN-ß to counteract viral infection. CONCLUSIONS: Both Radix Glycyrrhizae and Radix Glycyrrhizae Preparata are effective against HRSV infection on airway epithelial cells. Radix Glycyrrhizae inhibited HRSV mainly by preventing viral attachment, internalization, and by stimulating IFN secretion. 18ß-GA may be one of its active constituents.


Asunto(s)
Antivirales/farmacología , Glycyrrhiza/química , Extractos Vegetales/farmacología , Virus Sincitial Respiratorio Humano/efectos de los fármacos , Sistema Respiratorio/efectos de los fármacos , Sistema Respiratorio/virología , Antivirales/química , Línea Celular , Medicamentos Herbarios Chinos/química , Medicamentos Herbarios Chinos/farmacología , Ácido Glicirretínico/análogos & derivados , Ácido Glicirretínico/química , Ácido Glicirretínico/farmacología , Ácido Glicirrínico/química , Ácido Glicirrínico/farmacología , Humanos , Interferón beta/metabolismo , Extractos Vegetales/química , Plantas Medicinales/química , Mucosa Respiratoria/efectos de los fármacos , Mucosa Respiratoria/metabolismo , Infecciones por Virus Sincitial Respiratorio/tratamiento farmacológico , Infecciones por Virus Sincitial Respiratorio/metabolismo , Sistema Respiratorio/metabolismo , Replicación Viral/efectos de los fármacos , Agua/química
10.
J Ethnopharmacol ; 147(2): 481-7, 2013 May 20.
Artículo en Inglés | MEDLINE | ID: mdl-23542148

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Xiao-Qing-Long-Tang (XQLT, TJ-19, Sho-seiryu-to, so-cheong-ryong-tang) has been used against acute airway diseases for thousands of year in ancient China. Most of the acute airway illnesses are caused by virus. However, without activity against influenza virus, XQLT has been questioned to manage respiratory tract viral infection. Nevertheless, XQLT might be active against airway viruses other than influenza. Human respiratory syncytial virus (HRSV) is one of the most common respiratory viral pathogens without effective management. However, it is unknown whether XQLT has anti-HRSV activity. AIM OF THE STUDY: We tested the hypothesis that XQLT can effectively minimize HRSV-induced plaque formation in respiratory tract mucosal cell lines. MATERIALS AND METHODS: Anti-HRSV activity of a hot water extract of XQLT was examined by plaque reduction assay in both human upper (HEp-2) and low (A549) respiratory tract cell lines. Its effects on syncytial formation and viral fusion (F) protein were examined directly by microscopy and by western blot, respectively. Ability of XQLT to stimulate IFN-ß was evaluated by enzyme-linked immunosorbent assay (ELISA). RESULTS: Hot water extract of XQLT dose-dependently inhibited HRSV-induced plaque formation in both HEp-2 and A549 cells (P<0.0001), particularly when given before viral inoculation (p<0.0001). XQLT inhibited viral attachment (p<0.0001) and internalization (p<0.0001). 300µg/ml XQLT could decrease both the number and the size of HRSV-induced syncytium without clear effect on the production of viral F protein. XQLT could stimulate epithelial cells to secrete IFN-ß before and after viral inoculation to counteract viral infection (p<0.0001). CONCLUSIONS: XQLT is effective against HRSV infection on airway epithelia by preventing viral attachment, internalization, syncytial formation, and by stimulating interferon secretion.


Asunto(s)
Antivirales/farmacología , Medicamentos Herbarios Chinos/farmacología , Virus Sincitial Respiratorio Humano/efectos de los fármacos , Línea Celular Tumoral , Humanos , Interferón beta/metabolismo , Infecciones por Virus Sincitial Respiratorio/metabolismo , Infecciones por Virus Sincitial Respiratorio/virología , Virus Sincitial Respiratorio Humano/fisiología , Sistema Respiratorio/virología , Ensayo de Placa Viral , Acoplamiento Viral/efectos de los fármacos , Internalización del Virus/efectos de los fármacos
11.
Dev Comp Immunol ; 41(3): 341-51, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23542704

RESUMEN

Macrophages (MPh) and dendritic cells (DC) are members of the mononuclear phagocyte system. In chickens, markers to distinguish MPh from DC are lacking, but whether MPh and DC can be distinguished in humans and mice is under debate, despite the availability of numerous markers. Mucosal MPh and DC are strategically located to ingest foreign antigens, suggesting they can rapidly respond to invading pathogens. This review addresses our current understanding of DC and MPh function, the receptors expressed by MPh and DC involved in pathogen recognition, and the responses of DC and MPh against respiratory and intestinal pathogens in the chicken. Furthermore, potential opportunities are described to modulate MPh and DC responses to enhance disease resistance, highlighting modulation through nutraceuticals and vaccination.


Asunto(s)
Pollos/inmunología , Células Dendríticas/inmunología , Tracto Gastrointestinal/inmunología , Macrófagos/inmunología , Sistema Respiratorio/inmunología , Animales , Coccidiosis/inmunología , Coccidiosis/prevención & control , Células Dendríticas/microbiología , Células Dendríticas/parasitología , Células Dendríticas/virología , Suplementos Dietéticos/estadística & datos numéricos , Infecciones por Escherichia coli/inmunología , Infecciones por Escherichia coli/prevención & control , Tracto Gastrointestinal/microbiología , Tracto Gastrointestinal/parasitología , Tracto Gastrointestinal/virología , Inmunidad Innata , Inmunomodulación , Gripe Aviar/inmunología , Gripe Aviar/prevención & control , Receptores de Lipopolisacáridos/genética , Receptores de Lipopolisacáridos/inmunología , Macrófagos/microbiología , Macrófagos/parasitología , Macrófagos/virología , Sistema Respiratorio/microbiología , Sistema Respiratorio/parasitología , Sistema Respiratorio/virología , Lectinas Similares a la Inmunoglobulina de Unión a Ácido Siálico/genética , Lectinas Similares a la Inmunoglobulina de Unión a Ácido Siálico/inmunología , Vacunación/estadística & datos numéricos
12.
J Ethnopharmacol ; 145(1): 146-51, 2013 Jan 09.
Artículo en Inglés | MEDLINE | ID: mdl-23123794

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Ginger, Zingiber officinale Roscoe, is a common spice and also a widely used medicinal plant in ancient China. Ginger is an ingredient of Ge-Gen-Tang (Kakkon-to; GGT). GGT has been proved to have antiviral activity against human respiratory syncytial virus (HRSV). However, it is unknown whether ginger is effective against HRSV. AIM OF THE STUDY: To find a readily available agent to manage HRSV infection, the authors tested the hypothesis that ginger can effectively decrease HRSV-induced plaque formation in respiratory mucosal cell lines. MATERIALS AND METHODS: Effect of hot water extracts of fresh and dried gingers on HRSV was tested by plaque reduction assay in both human upper (HEp-2) and low (A549) respiratory tract cell lines. Ability of ginger to stimulate anti-viral cytokines was evaluated by enzyme-linked immunosorbent assay (ELISA). RESULTS: Fresh ginger dose-dependently inhibited HRSV-induced plaque formation in both HEp-2 and A549 cell lines (p<0.0001). In contrast, dried ginger didn't show any dose-dependent inhibition. 300 µg/ml fresh ginger could decrease the plaque counts to 19.7% (A549) and 27.0% (HEp-2) of that of the control group. Fresh ginger was more effective when given before viral inoculation (p<0.0001), particularly on A549 cells. 300 µg/ml fresh ginger could decrease the plaque formation to 12.9% when given before viral inoculation. Fresh ginger dose-dependently inhibited viral attachment (p<0.0001) and internalization (p<0.0001). Fresh ginger of high concentration could stimulate mucosal cells to secrete IFN-ß that possibly contributed to counteracting viral infection. CONCLUSIONS: Fresh, but not dried, ginger is effective against HRSV-induced plaque formation on airway epithelium by blocking viral attachment and internalization.


Asunto(s)
Antivirales/farmacología , Extractos Vegetales/farmacología , Sistema Respiratorio/efectos de los fármacos , Zingiber officinale/química , Antivirales/química , Línea Celular , Supervivencia Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Medicamentos Herbarios Chinos/farmacología , Humanos , Interferón beta/metabolismo , Pruebas de Sensibilidad Microbiana/métodos , Extractos Vegetales/química , Virus Sincitial Respiratorio Humano/efectos de los fármacos , Sistema Respiratorio/metabolismo , Sistema Respiratorio/virología , Factor de Necrosis Tumoral alfa/metabolismo , Ensayo de Placa Viral/métodos , Agua/química
13.
Am J Chin Med ; 40(1): 151-62, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22298455

RESUMEN

Human respiratory syncytial virus (HRSV) causes serious pediatric infection of the lower respiratory tract without effective therapeutic modality. Sheng-Ma-Ge-Gen-Tang (SMGGT; Shoma-kakkon-to) has been proven to be effective at inhibiting HRSV-induced plaque formation, and Cimicifuga foetida is the major constituent of SMGGT. We tested the hypothesis that C. foetida effectively inhibited the cytopathic effects of HRSV by a plaque reduction assay in both human upper (HEp2) and lower (A549) respiratory tract cell lines. Its ability to stimulate anti-viral cytokines was evaluated by an enzyme-linked immunosorbent assay (ELISA). C. foetida dose-dependently inhibited HRSV-induced plaque formation (p < 0.0001) before and after viral inoculation, especially in A549 cells (p < 0.0001). C. foetida dose-dependently inhibited viral attachment (p < 0.0001) and could increase heparins effect on viral attachment. In addition, C. foetida time-dependently and dose-dependently (p < 0.0001) inhibited HRSV internalization. C. foetida could stimulate epithelial cells to secrete IFN-ß to counteract viral infection. However, C. foetida did not stimulate TNF-α secretion. Therefore, C. foetida could be useful in managing HRSV infection. This is the first evidence to support that C. foetida possesses antiviral activity.


Asunto(s)
Actaea , Antivirales/uso terapéutico , Cimicifuga , Medicamentos Herbarios Chinos/uso terapéutico , Fitoterapia , Infecciones por Virus Sincitial Respiratorio/tratamiento farmacológico , Virus Sincitial Respiratorio Humano/efectos de los fármacos , Antivirales/farmacología , Línea Celular , Relación Dosis-Respuesta a Droga , Medicamentos Herbarios Chinos/farmacología , Ensayo de Inmunoadsorción Enzimática , Células Epiteliales/efectos de los fármacos , Células Epiteliales/metabolismo , Heparina/farmacología , Humanos , Interferón beta/metabolismo , Infecciones por Virus Sincitial Respiratorio/metabolismo , Infecciones por Virus Sincitial Respiratorio/virología , Virus Sincitial Respiratorio Humano/patogenicidad , Sistema Respiratorio/efectos de los fármacos , Sistema Respiratorio/virología , Factor de Necrosis Tumoral alfa/metabolismo , Ensayo de Placa Viral , Integración Viral/efectos de los fármacos
14.
J Ethnopharmacol ; 137(3): 1149-55, 2011 Oct 11.
Artículo en Inglés | MEDLINE | ID: mdl-21810459

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Liu-He-Tang (LHT) has been used to treat adult respiratory tract infection with productive cough and fever for a thousand years in ancient China. Adults with respiratory tract infection of human respiratory syncytial virus (HRSV) can have symptoms similar to those managed by LHT. Therefore, LHT is supposed to be beneficial for adult HRSV infection. However, LHT does not have any antiviral activity to support its use against HRSV infection. AIM OF THE STUDY: HRSV is the most important virus causing serious pediatric respiratory tract infections worldwide. HRSV also contributes considerably to respiratory tract illness in adults. There is no effective therapeutic modality against HRSV infection. In order to find readily available agents to manage adult HRSV infection, this study tested the hypothesis that LHT has antiviral activity against HRSV-induced cytopathy. MATERIALS AND METHODS: Effect of the hot water extract of LHT on HRSV was tested by plaque reduction assay in both human upper (HEp-2) and low (A549) respiratory tract cell lines and also a human normal fibroblast cell line (WI-38). Ability of LHT to stimulate anti-viral cytokines was evaluated by enzyme-linked immunosorbent assay (ELISA). RESULTS: LHT could dose-dependently inhibit HRSV-induced plaque formation (p < 0.0001), especially in A549 cell. 300 µg/ml LHT nearly abolished plaque formation in A549 cells. LHT was more effective when given before viral inoculation (p < 0.0001). LHT dose-dependently inhibited viral attachment (p < 0.0001). Besides, LHT could inhibit HRSV internalization both time-dependently and dose-dependently (p < 0.0001). Furthermore, LHT stimulated epithelial cells to secrete IFN-ß and TNF-α to counteract HRSV infection before infection becomes established. CONCLUSIONS: LHT has anti-HRSV activity that provides a basic support of its possible use in managing adult HRSV infection.


Asunto(s)
Antivirales/farmacología , Medicamentos Herbarios Chinos/farmacología , Infecciones por Virus Sincitial Respiratorio/tratamiento farmacológico , Virus Sincitial Respiratorio Humano/efectos de los fármacos , Sistema Respiratorio/efectos de los fármacos , Línea Celular , Efecto Citopatogénico Viral/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Ensayo de Inmunoadsorción Enzimática , Humanos , Interferón beta/metabolismo , Infecciones por Virus Sincitial Respiratorio/inmunología , Infecciones por Virus Sincitial Respiratorio/virología , Virus Sincitial Respiratorio Humano/crecimiento & desarrollo , Sistema Respiratorio/inmunología , Sistema Respiratorio/virología , Factores de Tiempo , Factor de Necrosis Tumoral alfa/metabolismo , Ensayo de Placa Viral , Acoplamiento Viral/efectos de los fármacos , Internalización del Virus/efectos de los fármacos
15.
J Ethnopharmacol ; 135(2): 538-44, 2011 May 17.
Artículo en Inglés | MEDLINE | ID: mdl-21463671

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Sheng-Ma-Ge-Gen-Tang (SMGGT; Shoma-kakkon-to) has been used against pediatric viral infection for thousands of year in ancient China. However, it is unknown whether SMGGT is effective against human respiratory syncytial virus (HRSV). AIM OF THE STUDY: HRSV is a major pediatric viral pathogen of low respiratory tract infection without effective management. This study tested the hypothesis that SMGGT effectively inhibited cytopathy induced by HRSV. MATERIALS AND METHODS: Effect of the crude extract of SMGGT on HRSV was tested by plaque reduction assay in both human upper (HEp-2) and low (A549) respiratory tract cell lines. Ability of SMGGT to stimulate anti-viral cytokines was evaluated by enzyme-linked immunosorbent assay (ELISA). RESULTS: Crude extract of SMGGT dose-dependently inhibited HRSV-induced plaque formation. The crude extract was more effective when given before viral infection (p<0.0001). It inhibited viral attachment dose-dependently (p<0.0001) and could increase heparin effect on viral attachment. Furthermore, it was synergistic with very low-dose heparin on viral attachment. In addition, the crude extract time-dependently and dose-dependently (p<0.0001) inhibited HRSV internalization into HEp-2 cells. Epithelial cells secrete IFN-ß and TNF-α to counteract viral infection. The crude extract could stimulate epithelial cells to secrete these cytokines beforehand and become resistant to viral infection. It also stimulated IFN-ß to defense HRSV after viral inoculation. CONCLUSIONS: Sheng-Ma-Ge-Gen-Tang could be effective to manage HRSV infection in young children.


Asunto(s)
Efecto Citopatogénico Viral/efectos de los fármacos , Medicamentos Herbarios Chinos/farmacología , Medicina Tradicional China , Virus Sincitiales Respiratorios/efectos de los fármacos , Sistema Respiratorio/virología , Línea Celular , Humanos , Virus Sincitiales Respiratorios/patogenicidad , Sistema Respiratorio/citología
16.
J Immunol ; 178(10): 6320-31, 2007 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-17475861

RESUMEN

Porcine respiratory and reproductive syndrome virus (PRRSV) causes an extraordinary increase in the proportion of B cells resulting in lymphoid hyperplasia, hypergammaglobulinemia, and autoimmunity in neonatal piglets. Spectratypic analysis of B cells from neonatal isolator piglets show a non-Gaussian pattern with preferential expansion of clones bearing certain H chain third complementary region (HCDR3) lengths. However, only in PRRSV-infected isolator piglets was nearly the identical spectratype observed for all lymphoid tissues. This result suggests dissemination of the same dominant B cell clones throughout the body. B cell expansion in PRRS was not associated with preferential VH gene usage or repertoire diversification and these cells appeared to bear a naive phenotype. The B cell population observed during infection comprised those with hydrophobic HCDR3s, especially sequences encoded by reading frame 3 of DHA that generates the AMVLV motif. Thus, the hydropathicity profile of B cells after infection was skewed to favor those with hydrophobic binding sites, whereas the normally dominant region of the hydropathicity profile containing neutral HCDR3s was absent. We believe that the hypergammaglobulinemia results from the products of these cells. We speculate that PRRSV infection generates a product that engages the BCR of naive B cells, displaying the AMVLV and similar motifs in HCDR3 and resulting in their T-independent proliferation without repertoire diversification.


Asunto(s)
Anticuerpos Antivirales/biosíntesis , Diversidad de Anticuerpos/inmunología , Subgrupos de Linfocitos B/inmunología , Diferenciación Celular/inmunología , Proliferación Celular , Regiones Determinantes de Complementariedad/biosíntesis , Genitales/inmunología , Cadenas Pesadas de Inmunoglobulina/biosíntesis , Síndrome Respiratorio y de la Reproducción Porcina/inmunología , Sistema Respiratorio/inmunología , Animales , Animales Recién Nacidos , Anticuerpos Antivirales/sangre , Anticuerpos Antivirales/genética , Diversidad de Anticuerpos/genética , Subgrupos de Linfocitos B/citología , Subgrupos de Linfocitos B/metabolismo , Subgrupos de Linfocitos B/virología , Líquido del Lavado Bronquioalveolar/citología , Líquido del Lavado Bronquioalveolar/inmunología , Diferenciación Celular/genética , Regiones Determinantes de Complementariedad/sangre , Regiones Determinantes de Complementariedad/genética , Feto , Reordenamiento Génico de Cadena Pesada de Linfocito B , Genitales/virología , Interacciones Hidrofóbicas e Hidrofílicas , Cadenas Pesadas de Inmunoglobulina/sangre , Cadenas Pesadas de Inmunoglobulina/genética , Síndrome Respiratorio y de la Reproducción Porcina/virología , Virus del Síndrome Respiratorio y Reproductivo Porcino/inmunología , Sistema Respiratorio/virología , Porcinos , Distribución Tisular/genética , Distribución Tisular/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA